Juvenile myasthenia gravis

Neurology

Volumn 30, Issue 7, 1980, Pages 732-739

  Snead, O Carter ^a   Benton, John W ^a   Dwyer, Donard ^a   Morley, Barbara J ^a   Kemp, George E ^a   Bradley, Ronald J ^a   Oh, Shin J ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN G; NICOTINIC RECEPTOR; PREDNISONE; PYRIDOSTIGMINE;

DRUG THERAPY; MUSCLE; MYASTHENIA GRAVIS; PERIPHERAL NERVOUS SYSTEM; PRESCHOOL CHILD; SCHOOL CHILD; SEIZURE; THERAPY; THYMECTOMY; THYMUS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EYE MANIFESTATIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MYASTHENIA GRAVIS; PLASMAPHERESIS; PREDNISONE; PYRIDOSTIGMINE BROMIDE; RECEPTORS, NICOTINIC; SEIZURES;

EID: 0018976228     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.30.7.732     Document Type: Article

References (67)

1. Osserman KE, Genkins G: Studies in myasthenia gravis: Review of a twenty year experience in over 1200 patients. Mt Sinai J Med NY 38:497-537, 1971
2. Millichap JG, Dodge PR: Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescence: A study of 51 patients. Neurology (Minneap) 10:1007-1014, 1960
3. Fukuyama Y, Suzuki M, Segawa M: Studies on myasthenia gravis in childhood. Paed Univers Tokyo 18:57-68, 1970
4. Seybold ME, Howard FM, Duane DD, et al: Thymectomy in juvenile myasthenia gravis. Arch Neurol 25:385-392, 1971
5. Ryniewicz B, Badurska B: Followup study of myasthenic children after thymectomy. J Neurol 217:133-138, 1978
6. Bradley RJ, Dwyer D, Morley BJ, et al: Humoral immunity in myasthenia gravis: Relationship to disease severity and steroid treatment. Lancet 2:96, 1978
7. Fenichel GM: Clinical syndromes of myasthenia in infancy and childhood. Arch Neurol 35:97-103, 1978
8. Teng P, Osserman KE: Studies in myasthenia gravis: Neonatal and juvenile types. J Mt Sinai Hosp 23:711727, 1956
9. Bosch P, Reith PE, Granner DK: Myasthenia gravis and Schmidt syndrome. Neurology (Minneap) 27:1179-1180, 1977
10. Schlezinger NS, Corin MS: Myasthenia gravis associated with hyperthyroidism in childhood. Neurology (Minneap) 18:1217-1222, 1968
11. Silver S, Osserman KE: Hyperthyroidism and myasthenia gravis. J Mt. Sinai Hosp 24:1214-1221, 1957
12. Aarli JA, Thunold S, Heimann P: Thyroiditis in myasthenia gravis. Acta Neurol Scand 58:121-127, 1978
13. Schnakenberg RC, Holmes G: Coexisting childhood schizophrenia and myasthenia gravis treated successfully with neostigmine bromide. Am J Psychiatry 134:10251027, 1977
14. Gittleson NL, Richardson TDE: Myasthenia gravis and schizophrenia-A rare combination. Br J Psychiatry 122:343-344, 1973
15. Collins RT: Psychiatric syndromes in myasthenia gravis. Br Med J 1:975-977, 1939
16. Williams RL, Silberman M: Electric shock therapy in a case of myasthenia gravis complicated by a schizophrenic psychosis. Arch Neurol Psychiatry 66:783-786, 1951
17. Dorrell W: Myasthenia gravis and schizophrenia. Br J Psychiatry 123:249, 1974
18. Myer E: Psychological disturbances in myasthenia gravis. Ann NY Acad Sei 135:417-423, 1966
19. Houghton JB, Toghill PJ: Myasthenia gravis and red cell aplasia. Br Med J 4:1402-1403, 1978
20. Bryon PA, Viala JJ, Michel F, et al: Pancytopénie par aplasie myéloide et myasthénie associées à un thymome compressif. Lyon Med 223:1051-1056, 1970
21. Mackechnie HLN, Squires AH, Platts M, et al: Thymoma, myasthenia gravis, érythroblastopénie anemia and systemic lupus erythematosus in one patient. Can Med Assoc J 109:733-738, 1973
22. Durance RA: Myasthenia gravis, rheumatoid arthritis, vitiligo, and autoimmume hemolytic anemia. Proc R Soc Med 64:61-62, 1971
23. Sebikari SRK: Diabetes mellitus associated with myasthenia gravis in an African child. East Afr Med J 49:282284, 1972
24. Cohen SM, Tung BG, Sawitsky A: Myasthenia gravis and focal glomerulonephritis following idiopathic thrombocytopenic purpura: A possible common etiology. Mt Sinai J Med NY 37:687-690, 1970
25. Hokkanen E, Toivakka E: Electroencephalographic findings in myasthenia gravis. Acta Neurol Scand 45:556-567, 1969
26. Hoefer PFA, Aranow A, Rowland LP: Myasthenia gravis and epilepsy. Arch Neurol 80:10-17, 1958
27. Feamsides EG: Myasthenia gravis and epileptiform attacks observed over a period of 11 years. Proc R Soc Med 9:47-49, 1915
28. Sigwald J, Geets W, Raverdy P, et al: Deux observations d’association de myasthénie à une epilepsie de type petit mal chez des enfants. Rev Neurol (Paris) 113:651-654, 1965
29. Raynaud EJ, Toumilhac M, Janny P, et al: Myasthénie et comitialité: Association des deux syndromes chez une enfant. Nouv Presse Med 78:2074-2075, 1970
30. Hansson U, Irestedt L, Moberg PJ: Delivery complicated by myasthenia gravis and epilepsy. Acta Obstet Gynecol Scand 57:183-185, 1978
31. Mortier W, Schenk K, Kleu G: Gemeinsames Vorkommen von Myasthenia Gravis, Epilepsie und Struma im Kindesalter. Nervenarzt 42:498-501, 1971
32. Fulpius BW, Fontana A, Cuenoud S: Central nervous system involvement in experimental autoimmune myasthenia gravis. Lancet 2:350-351, 1977
33. Lefvert AK, Bergstrom K, Matell G, et al: Determination of acetylcholine receptor antibody in myasthenia gravis: Clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry 41:395-403, 1978
34. Fontana A, Fulpius BW, Cuenoud S: Antikörper gegen Nictotinartize Acetylcholinrezeptem des Zentralnervensystems und der Muskulatur bei Epileptikern mit lg A-mangel. Schweiz Med Wochenschr 108:1307-1310, 1978
35. Fontana A, Joller H, Skuaril F, et al: Immunological abnormalities and HLA antigen frequencies in IgA deficient patients with epilepsy. J Neurol Neurosurg Psychiatry 41:593-597, 1978
36. Fontana A, Grob PH: Immunodeficiency in epilepsy: A new view. J Neurol 220:297-301, 1979
37. Aharonov A, Tarrab-Hazdai R, Abramsky O: Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet 2:340-342, 1975
38. Mittag T, Kornfeld P, Tormay A, et al: Detection of acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis. N Engl J Med 294:691-694, 1976
39. Heilbronn E, Stalberg E: The pathogenesis of myasthenia gravis. J Neurochem 31:5-11, 1978
40. Heilbronn E, Lefvert A, Stalberg E: Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis. Muscle Nerve 1:427-431, 1978
41. Marengo TS, Harrison R, Lunt GG: Rat or human acetylcholine-receptor antigen for investigation of myasthenia gravis? Lancet 1:442, 1979
42. Lindstrom JM, Lennon VA, Seybold ME, et al: Experimental autoimmune myasthenia gravis: Biochemical and immunochemical aspects. Ann NY Acad Sei 274:254-274, 1976
43. Lindstrom J: An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathôl 7:36-43, 1977
44. Dwyer D, Morley BJ, Kemp GE, et al: Unpublished data
45. Lindstrom J, Seybold ME, Lennon VA, et al: Antibody to acetylcholine receptor in myasthenia gravis. Neurology (Minneap) 26:1054-1059, 1976
46. Seybold MJ, Baergen RN, Bave B, et al: Antiacetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis. Br Med J 2:1051, 1978
47. Scadding GK, Thomas HC, Havard CWH: Myasthenia gravis: Acetylcholine-receptor antibody titers after thymectomy. Br Med J 1:1512, 1977
48. Seybold ME, Lindstrom JM: Serial anti-acetylcholine receptor antibody titers in patients with myasthenia gravis: Effect of steroid therapy. In Dau PC (Editor): Plasmapheresis and the Immunobiology of Myasthenia Gravis. Boston, Houghton-Mifflin, 1979, pp 307-314
49. Newsom-Davis J, Pinching AJ, Vincent A, et al: Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange. Neurology 28:266-272, 1978
50. Newsom-Davis J, Vincent A, Wilson SG, et al: Long term effects of repeated plasma exchange in myasthenia gravis. Lancet 1:464-468, 1979
51. Newsom-Davis J, Ward CD, Wilson SG, et al: Plasmapheresis: Short and long term benefits? In Dau PC (Editor): Plasmapheresis and the Immunobiology of Myasthenia Gravis. Boston, Houghton-Mifflin, 1979, pp 199-208
52. Lisak RP, Abramsky O, Schotland DL: Plasmapheresis in the treatment of myasthenia gravis: Preliminary studies in 21 patients. In Dau PC (Editor): Plasmapheresis and the Immunobiology of Myasthenia Gravis. Boston, Houghton-Mifflin, 1979, pp 209-215
53. Fraser K, Simpson JA, Crawford J: The place of surgery in the treatment of myasthenia gravis. Br J Surg 65:301-304, 1978
54. Samat HB, McGarry JD, Lewis JE: Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy. Neurology (Minneap) 27:550-553, 1977
55. Fonkalsrud EW, Herrmann C, Mulder DG: Thymectomy for myasthenia gravis in children. J Pediatr Surg 5:157-165, 1970
56. Keynes G: Surgery of the thymus gland: Second and third thoughts. Lancet 1:1197-1201, 1954.
57. McQuillen MP, Leone MG: A treatment carol: Thymectomy revisited. Neurology (Minneap) 27:1105-1106, 1977
58. Mendell JR, Warmolts JR, Bass JC: Caution urged in childhood thymectomy for myasthenia gravis. Neurology (Minneap) 27:1182, 1977
59. Pinelli P, Tonali P, Scoppetta C: Long term treatment of myasthenia gravis with alternate day prednisone: Report on 15 patients. Eur Neurol 12:129-141, 1974
60. Warmolts JR, Engel WK: Benefit from alternate day prednisone in myasthenia gravis. N Engl J Med 286:17-20, 1972
61. Mann DS, John TR, Campa J: Long term administration of corticosteroids in myasthenia gravis. Neurology (Minneap) 26:729-740, 1976
62. Fischer KC, Schwartzmann RJ: Oral corticosteroids in the treatment of ocular myasthenia gravis. Neurology (Minneap) 24:795-798, 1974
63. Dau PC, Lindstrom JM, Cassel CK, et al: Plasmapheresis and immunosuppresssive drug therapy in myasthenia gravis. N Engl J Med 297:1134-1140, 1977
64. Papatestas AE, Albert LI, Osserman KE, et al: Studies in myasthenia gravis: Effects of thymectomy. Am J Med 50:465-474, 1971
65. Sambrook MA, Reid H, Mohr PD, et al: Myasthenia gravis: Clinical and histological features in relation to thymectomy. J Neurol Neurosurg Psychiatry 39:38-43, 1976
66. Reinglass JL, Brickel ACJ: The prognostic significance of thymic germinal center proliferation in myasthenia gravis. Neurology (Minneap) 23:69-72, 1973
67. Alpert IL, Papatestas A, Kark A, et al: A histological reappraisal of the thymus in myasthenia gravis. Arch Pathol 91:55-61, 1971